Genmab — Juni 2018
-
-
-
HuMax®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics
Company Announcement Genmab to pay Seattle Genetics, Inc. a milestone payment of USD 7 million under the Antibody-Drug Conjugate (ADC)...
GlobeNewswire News Room (www.globenewswire.com)
-
human AXL fremskridt, kan vel kun være gode tegn
-
Det betyder i det mindste, at det har vist sig sikkert at bruge det og at de har fundet den/de relevante dosis. The dose escalation part has two dose escalation arms: the first arm investigates a once every 3 weeks (1Q3W) dosing schedule and the second arm investigates a three administrations over 4 weeks (3Q4W) dosing schedule.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind